PHOTRONICS INC (PLAB) Fundamental Analysis & Valuation

NASDAQ:PLAB • US7194051022

Current stock price

44.9 USD
+0.42 (+0.94%)
At close:
45.22 USD
+0.32 (+0.71%)
After Hours:

This PLAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PLAB Profitability Analysis

1.1 Basic Checks

  • PLAB had positive earnings in the past year.
  • In the past year PLAB had a positive cash flow from operations.
  • In the past 5 years PLAB has always been profitable.
  • In the past 5 years PLAB always reported a positive cash flow from operatings.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 7.18%, PLAB is doing good in the industry, outperforming 73.91% of the companies in the same industry.
  • With a decent Return On Equity value of 11.27%, PLAB is doing good in the industry, outperforming 74.78% of the companies in the same industry.
  • The Return On Invested Capital of PLAB (9.96%) is better than 81.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PLAB is in line with the industry average of 10.70%.
Industry RankSector Rank
ROA 7.18%
ROE 11.27%
ROIC 9.96%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • PLAB has a Profit Margin of 15.83%. This is in the better half of the industry: PLAB outperforms 75.65% of its industry peers.
  • PLAB's Profit Margin has improved in the last couple of years.
  • PLAB has a better Operating Margin (24.45%) than 82.61% of its industry peers.
  • PLAB's Operating Margin has improved in the last couple of years.
  • PLAB has a worse Gross Margin (35.14%) than 61.74% of its industry peers.
  • PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.45%
PM (TTM) 15.83%
GM 35.14%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PLAB Health Analysis

2.1 Basic Checks

  • PLAB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for PLAB has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PLAB has less shares outstanding
  • Compared to 1 year ago, PLAB has an improved debt to assets ratio.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • PLAB has an Altman-Z score of 4.17. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
  • PLAB has a Altman-Z score (4.17) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of PLAB is 0.00, which is an excellent value as it means it would take PLAB, only 0.00 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of PLAB (0.00) is better than 86.09% of its industry peers.
  • PLAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.00, PLAB is doing good in the industry, outperforming 72.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.17
ROIC/WACC0.86
WACC11.62%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PLAB has a Current Ratio of 4.58. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.58, PLAB is in the better half of the industry, outperforming 66.96% of the companies in the same industry.
  • PLAB has a Quick Ratio of 4.28. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • PLAB has a Quick ratio of 4.28. This is in the better half of the industry: PLAB outperforms 72.17% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 4.28
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. PLAB Growth Analysis

3.1 Past

  • PLAB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.92%.
  • The Earnings Per Share has been growing by 30.81% on average over the past years. This is a very strong growth
  • Looking at the last year, PLAB shows a decrease in Revenue. The Revenue has decreased by -0.06% in the last year.
  • The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
Revenue 1Y (TTM)-0.06%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.62% on average over the next years.
  • The Revenue is expected to grow by 5.44% on average over the next years.
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.92%
Revenue Next 2Y5.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. PLAB Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 21.18, the valuation of PLAB can be described as rather expensive.
  • PLAB's Price/Earnings ratio is rather cheap when compared to the industry. PLAB is cheaper than 89.57% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of PLAB to the average of the S&P500 Index (26.78), we can say PLAB is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 19.83, PLAB is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 86.09% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, PLAB is valued at the same level.
Industry RankSector Rank
PE 21.18
Fwd PE 19.83
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than PLAB, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PLAB is valued a bit cheaper than the industry average as 79.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 40.17
EV/EBITDA 6.59
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PLAB does not grow enough to justify the current Price/Earnings ratio.
  • PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.01
PEG (5Y)0.69
EPS Next 2Y5.62%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PLAB Dividend Analysis

5.1 Amount

  • PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLAB Fundamentals: All Metrics, Ratios and Statistics

PHOTRONICS INC

NASDAQ:PLAB (4/10/2026, 8:00:01 PM)

After market: 45.22 +0.32 (+0.71%)

44.9

+0.42 (+0.94%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-11
Earnings (Next)05-26
Inst Owners98.63%
Inst Owner Change0%
Ins Owners3.74%
Ins Owner Change1.66%
Market Cap2.65B
Revenue(TTM)862.22M
Net Income(TTM)136.49M
Analysts84.44
Price Target47.19 (5.1%)
Short Float %4.63%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.69%
Min EPS beat(2)4.01%
Max EPS beat(2)29.38%
EPS beat(4)3
Avg EPS beat(4)11.48%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.67%
EPS beat(12)7
Avg EPS beat(12)6.65%
EPS beat(16)9
Avg EPS beat(16)6%
Revenue beat(2)1
Avg Revenue beat(2)0.98%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)3.08%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.06%
Revenue beat(12)4
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-0.65%
PT rev (1m)9.25%
PT rev (3m)7.02%
EPS NQ rev (1m)8%
EPS NQ rev (3m)8.72%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-0.95%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 21.18
Fwd PE 19.83
P/S 3.07
P/FCF 40.17
P/OCF 9.93
P/B 2.19
P/tB 2.19
EV/EBITDA 6.59
EPS(TTM)2.12
EY4.72%
EPS(NY)2.26
Fwd EY5.04%
FCF(TTM)1.12
FCFY2.49%
OCF(TTM)4.52
OCFY10.07%
SpS14.62
BVpS20.54
TBVpS20.54
PEG (NY)3.01
PEG (5Y)0.69
Graham Number31.3
Profitability
Industry RankSector Rank
ROA 7.18%
ROE 11.27%
ROCE 12.44%
ROIC 9.96%
ROICexc 15.95%
ROICexgc 15.95%
OM 24.45%
PM (TTM) 15.83%
GM 35.14%
FCFM 7.65%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
ROICexc(3y)20.09%
ROICexc(5y)18.3%
ROICexgc(3y)20.09%
ROICexgc(5y)18.3%
ROCE(3y)15.36%
ROCE(5y)14.68%
ROICexgc growth 3Y-10.62%
ROICexgc growth 5Y18.95%
ROICexc growth 3Y-10.62%
ROICexc growth 5Y19.05%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 261.92%
Cap/Sales 23.27%
Interest Coverage 250
Cash Conversion 92.74%
Profit Quality 48.3%
Current Ratio 4.58
Quick Ratio 4.28
Altman-Z 4.17
F-Score5
WACC11.62%
ROIC/WACC0.86
Cap/Depr(3y)187.79%
Cap/Depr(5y)164.84%
Cap/Sales(3y)17.34%
Cap/Sales(5y)16.42%
Profit Quality(3y)93.18%
Profit Quality(5y)98.28%
High Growth Momentum
Growth
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.06%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.09%
Revenue Next Year5.92%
Revenue Next 2Y5.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.48%
EBIT growth 3Y-0.59%
EBIT growth 5Y26.64%
EBIT Next Year48.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.78%
FCF growth 3Y-28.46%
FCF growth 5Y-3.72%
OCF growth 1Y-15.63%
OCF growth 3Y-3.44%
OCF growth 5Y11.62%

PHOTRONICS INC / PLAB Fundamental Analysis FAQ

What is the fundamental rating for PLAB stock?

ChartMill assigns a fundamental rating of 6 / 10 to PLAB.


Can you provide the valuation status for PHOTRONICS INC?

ChartMill assigns a valuation rating of 5 / 10 to PHOTRONICS INC (PLAB). This can be considered as Fairly Valued.


Can you provide the profitability details for PHOTRONICS INC?

PHOTRONICS INC (PLAB) has a profitability rating of 7 / 10.


What is the expected EPS growth for PHOTRONICS INC (PLAB) stock?

The Earnings per Share (EPS) of PHOTRONICS INC (PLAB) is expected to grow by 7.02% in the next year.